Share Information
| Currency | Egyptian Pound (EGP) |
| Market | Egyptian Stock Exchange (EGX) |
| Sector | Health Care & Pharmaceuticals |
| Ticker | ISPH.CA |
| ISIN Code | EGS512O1C012 |
| Date of Listing | 8 / 11 / 2017 |
| Number of Listed Shares | 1,008,000,000 |
| Par Value / Share | 0.25 EGP (twenty five piasters) |
| Authorized Capital | 1,000,000,000 EGP (one billion Egyptian Pounds) |
| Issued Capital | 252,000,000 EGP (two hundred and fifty two million Egyptian Pounds) |
| Paid-Up Capital | 252,000,000 EGP (two hundred and fifty two million Egyptian Pounds) |
Shareholder Structure
Ibnsina Pharma’s shareholders include prominent members of the Egyptian business community and large institutional shareholders that have allowed the company to significantly enhance its corporate governance practices and systems. The company’s shareholders include the Mahgoub family (12.9%), the Abdel Gawad family (15.0%), the European Bank for Reconstruction and Development (EBRD) (9.6%), Faisal Islamic Bank (14.0%), and Blom Inv. (7.8%)
Corporate Info
| Year Founded | 2001 |
| Commercial Registration Number | Commercial Registration number 10724 dated 28/8/2017 Commercial Registry Office, Cairo |
| Fiscal Year | 1 January – 31 December |
| Law of Governance | Law (159) 1981 |
| Purpose of Company | Ibnsina-Pharma is a public company, listed on Egyptian Exchange (EGX) since December 2017. Ibnsina-Pharma operates within the pharmaceuticals, biotechnology & life sciences sector focusing on pharmaceuticals. IbnSina- Pharma is based in Cairo, Egypt |
| Auditor Name | Khaled El Ghannam, Eissa Refai & Co. |
| Headquarters | Obour City, Industrial Zone 1, Block 12015, Egypt |
| Subsidiaries | AIM for Investment and Consulting in Healthcare |
| Board of Directors | – Abdel Aziz Ali – Mohsen Mahgoub – Raafat Mokbel Hussein – Mahmoud Abdel Gawad – Omar Abdel Gawad – Ahmed Abdel Gawad – Mohamed Mahgoub – Mohamed Zaki – Sahar Nasr – Hoda Wally |
Listing Information
IPO and Secondary Market Public Offering
Ibnsina-Pharma S.A.E. intends to proceed with an initial public offering on the Egyptian Exchange (the “Offering”) that is expected to consist of a primary Offering of newly issued shares and a secondary Offering of existing shares held by the Company’s current shareholders (collectively the “Shares”) constituting up to 38% of Ibnsina-Pharma’s total shares. Proceeds from the transaction will be used to grow Ibnsina’s core distribution business and support its expansion into new, higher-margin revenue streams. The Offering is expected to take place in late Q4 2017 or early Q1 2018, subject to market conditions and the receipt of regulatory approvals.
Ibnsina-Start-of-Trading-Announcement-E
Ibnsina-Retail-Offering-Announcement-E-FINAL
Ibnsina-Final-Price-Announcement (1)
Insider transactions
| Trader | Type | Volume | Last Update |
|---|---|---|---|
| Undisclosed | Sell | 300,000 | 04 January 2024 |
| Undisclosed | Sell | 500,000 | 02 January 2024 |
| Undisclosed | Buy | 50,000 | 24 December 2023 |
| Undisclosed | Buy | 200,000 | 21 December 2023 |
| Undisclosed | Sell | 300,000 | 19 December 2023 |
| Undisclosed | Sell | 200,000 | 18 December 2023 |
| Undisclosed | Sell | 500,000 | 17 December 2023 |
| Undisclosed | Sell | 1,000,000 | 14 December 2023 |
| Undisclosed | Sell | 600,000 | 13 December 2023 |
| Undisclosed | Sell | 100,000 | 12 December 2023 |
| Undisclosed | Sell | 500,000 | 11 December 2023 |
| Undisclosed | Sell | 500,000 | 10 December 2023 |
| Undisclosed | Sell | 100,000 | 07 December 2023 |
| Undisclosed | Sell | 300,000 | 30 November 2023 |
| Undisclosed | Sell | 200,000 | 20 November 2023 |
| Undisclosed | Sell | 500,000 | 19 November 2023 |
| Undisclosed | Sell | 75,000 | 19 June 2023 |
| Undisclosed | Buy | 878,983 | 15 December 2022 |
| Undisclosed | Buy | 700,000 | 14 December 2022 |
| Undisclosed | Sell | 1,500,000 | 12 January 2022 |
| Undisclosed | Sell | 1,013,134 | 29 November 2021 |
| Undisclosed | Buy | 1,013,134 | 29 November 2021 |
| Undisclosed | Buy | 24,315,216 | 29 July 2021 |
| Undisclosed | Sell | 24,315,216 | 29 July 2021 |
| Undisclosed | Buy | 25,000 | 07 June 2021 |
| Undisclosed | Buy | 100,000 | 02 June 2021 |
| Undisclosed | Sell | 935,000 | 11 February 2021 |
| Undisclosed | Sell | 950,000 | 26 January 2021 |
| Undisclosed | Buy | 80,000 | 17 December 2020 |
| Undisclosed | Buy | 70,000 | 16 December 2020 |
| Undisclosed | Buy | 7,600 | 14 January 2020 |
| Undisclosed | Buy | 3,000 | 05 January 2020 |
| European Bank for Reconstruction and Development | Sell | 11,419,999 | 05 September 2019 |
| Mohamed Mohsen Mohamed Mahgoub | Sell | 7,500,000 | 05 September 2019 |
| Undisclosed | Sell | 230,000 | 20 August 2019 |
| Undisclosed | Sell | 194,219 | 14 August 2019 |
| Undisclosed | Sell | 1,600,000 | 08 August 2019 |
| Undisclosed | Sell | 250,000 | 03 June 2019 |
| Undisclosed | Buy | 5,200 | 08 April 2019 |
| Undisclosed | Buy | 1,858 | 04 April 2019 |
| Undisclosed | Sell | 745 | 03 April 2019 |
| Undisclosed | Buy | 3,300 | 31 December 2018 |
| Undisclosed | Buy | 2,200 | 30 December 2018 |
| Undisclosed | Buy | 1,771 | 25 December 2018 |
| Undisclosed | Sell | 1,137 | 04 December 2018 |
| Undisclosed | Buy | 1,000 | 18 October 2018 |
| Undisclosed | Buy | 23,100 | 17 October 2018 |
| Undisclosed | Buy | 3,125 | 10 October 2018 |
| Undisclosed | Buy | 950 | 09 October 2018 |
| Undisclosed | Buy | 10,100 | 08 October 2018 |
| Undisclosed | Buy | 3,000 | 04 October 2018 |
| Undisclosed | Buy | 1,000 | 01 October 2018 |
| Undisclosed | Sell | 341,378 | 28 June 2018 |
| Undisclosed | Buy | 82,390 | 19 February 2018 |
| Undisclosed | Buy | 10,000 | 18 February 2018 |
| Undisclosed | Buy | 20,000 | 06 February 2018 |
| Undisclosed | Buy | 23,480 | 05 February 2018 |
| Undisclosed | Buy | 13,712 | 04 February 2018 |
| Undisclosed | Buy | 50,000 | 25 December 2017 |
| Undisclosed | Buy | 8,100 | 21 December 2017 |
| Undisclosed | Buy | 1,530 | 17 December 2017 |
| Undisclosed | Buy | 6,760 | 14 December 2017 |